Clinical Trial Update: The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating prucalopride for constipation-predominant irritable bowel syndrome (IBS-C).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN